Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03767855 · ClinicalTrials.gov registry record · Phase 1
A Single and Multiple Ascending Dose Study of CK-3773274 in Healthy Adult Subjects
A Phase 1 study, sponsored by Cytokinetics.
- Completed
- Registry status
- Phase 1
- Development phase
- 114
- Enrollment target
NCT03767855 is a Phase 1 study that has completed, run by Cytokinetics. The registered enrollment target is 114 participants.
The verdict
NCT03767855, a Phase 1 study, has completed, sponsored by Cytokinetics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 114 participants
- Enrollment target
Study Summary
The purposes of this study are to: 1. Learn about the safety of CK-3773274 after a single dose and multiple doses in healthy subjects. 2. Learn how healthy subjects tolerate CK-3773274 after a single dose and multiple doses. 3. Find out how much CK-3773274 is in the blood after a single dose and multiple doses. 4. Determine the effect of doses of CK-3773274 on the pumping function of the heart. 5. Evaluate the effect of cytochrome genetic variants on how the body metabolizes CK-3773274. 6. Evaluate the effect of a meal on how much CK-3773274 is in the blood in healthy adult subjects. 7. Evaluate whether the amount of CK-3773274 in the blood is the similar for both the tablet and granules in capsule forms of the drug.
Interventions
- DRUG CK-3773274 - Granules in Capsule
- DRUG Placebo - Granules in Capsule
- DRUG CK-3773274 - Tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2018-12-04 |
| Est. Completion | 2020-01-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03767855
The ClinicalTrials.gov registry entry for NCT03767855 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 114 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cytokinetics, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which CK-3773274 - Granules in Capsule is the first listed.
NCT03767855 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03767855 about?
NCT03767855 is a clinical study titled "A Single and Multiple Ascending Dose Study of CK-3773274 in Healthy Adult Subjects". The purposes of this study are to: 1. Learn about the safety of CK-3773274 after a single dose and multiple doses in healthy subjects. 2. Learn how healthy subjects tolerate CK-3773274 after a single dose and multiple doses. 3. Find out how much CK-3773274 is in the blood after a single dose and mu...
What is the current status of trial NCT03767855?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 114 participants. The study started on 2018-12-04. Estimated completion is 2020-01-03.
What interventions are being tested in trial NCT03767855?
The interventions under investigation include: CK-3773274 - Granules in Capsule (DRUG), Placebo - Granules in Capsule (DRUG), CK-3773274 - Tablets (DRUG).
Who is sponsoring clinical trial NCT03767855?
This trial is sponsored by Cytokinetics, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.